Bottom line
Is FKASX a good fund? The bottom line
FKASX is the Class A share class of Federated Hermes Kaufmann Small Cap Fund, a managed small-cap mutual fund from Federated Hermes.
It charges 1.36% — about $136 a year on every $10,000 invested, more expensive than 80% of small-cap funds we track.
It returned +2.9% over one year, +3.5% a year over five years, +10.0% a year over ten (as of Dec 31, 2024, per its prospectus).
With $2.8 billion in net assets and 149 holdings, its largest position is Comfort Systems USA Inc (4.2%) and the top 10 make up 27% of the portfolio.
This share class carries a front-end sales charge of up to 5.5%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.36%)
- 5-year return in the bottom quarter of its category
- Front-end sales load up to 5.5%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What FKASX invests in
The Funds investment objective is to provide capital appreciation.
The Fund pursues its investment objective by investing primarily in the common stocks of small companies that are traded on national security exchanges, the NASDAQ stock market and on the over-the-counter market. Small companies will be defined as companies with market capitalizations that are between the lowest and highest market capitalizations, as measured on a rolling basis over the most recent 36-month period, in either the Russell 2000 Index (which had a rolling 36-month market capitalization range of $1.2 million to $56.5 billion as of October 31, 2025), the S&P Small Cap 600 Index (which had a rolling 36-month market capitalization range of $62.1 million to $29.1 billion as of October 31, 2025), or the MSCI USA Small Cap Index (which had a rolling 36-month market capitalization range of $8.5 million to $40.3 billion as of October 31, 2025). The Fund will normally invest at…
From the fund's prospectus (filed Dec 29, 2025).
FKASX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| FKASX | +2.9% | +3.5% | +10.0% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2024
What FKASX costs
On a $10,000 investment, FKASX's 1.36% expense ratio costs about $136 a year. The prospectus estimates $2,252 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
FKASX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Comfort Systems USA Inc FIX | 4.19% |
| 2 | Argenx SE ARGX | 3.53% |
| 3 | Guardant Health Inc GH | 3.34% |
| 4 | Ati Inc ATI | 3.01% |
| 5 | Forte Biosciences Inc | 2.24% |
| 6 | Viking Holdings Ltd VIK | 2.23% |
| 7 | Camtek Ltd/Israel CAMT | 2.14% |
| 8 | Rhythm Pharmaceuticals Inc RYTM | 2.13% |
| 9 | Ul Solutions Inc ULS | 2.12% |
| 10 | Sitime Corp SITM | 2.09% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 27% of the fund. See all top 25 holdings and asset mix →